Diferencia entre revisiones de «Template:GC Conjunctivitis Treatment»
Sin resumen de edición |
|||
| Línea 7: | Línea 7: | ||
====[[gonorrheal conjunctivitis|Gonococcal]]==== | ====[[gonorrheal conjunctivitis|Gonococcal]]==== | ||
*Due to increasing resistance, CDC recommends dual therapy with Ceftriaxone and Azithromycin (even if patient is negative for Chlamydia). | *Due to increasing resistance, CDC recommends dual therapy with Ceftriaxone and Azithromycin (even if patient is negative for Chlamydia). | ||
*[[Ceftriaxone]] | *[[Ceftriaxone]] 250mg IM one dose PLUS | ||
*[[Azithromycin]] 1g PO one dose | *[[Azithromycin]] 1g PO one dose | ||
*'''Newborn Treatment:''' | *'''Newborn Treatment:''' | ||
Revisión del 05:42 16 nov 2019
Chlamydial
- Doxycycline 100mg PO BID for 7 days OR
- Azithromycin 1g (20mg/kg) PO one time dose
- Newborn Treatment: Azithromycin 20mg/kg PO once daily x 3 days
- Disease manifests 5 days post-birth to 2 weeks (late onset)
Gonococcal
- Due to increasing resistance, CDC recommends dual therapy with Ceftriaxone and Azithromycin (even if patient is negative for Chlamydia).
- Ceftriaxone 250mg IM one dose PLUS
- Azithromycin 1g PO one dose
- Newborn Treatment:
- Prophylaxis: Erythromycin ophthalmic 0.5% x1
- Disease manifests 1st 5 days post delivery (early onset)
- Treatment Ceftriaxone 25-50mg IV or IM, max 125mg